REFI
HTGM

Requisite Energy Fund I’s HTG Molecular Diagnostics, Inc. Common Stock HTGM Stock Holding History

Requisite Energy Fund I’s Portfolio HTGM Stock Details HTGM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		$254K Buy
+556
New +$345K 0.1% 52

Other funds holding HTGM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
BRWA
B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Requisite Energy Fund I's HTGM Position: Q4 2018 in Review

Requisite Energy Fund I opened a new position in HTG Molecular Diagnostics, Inc. Common Stock (HTGM) in Q4 2018: 556 shares worth $254K. The stake represents 0.1% of the portfolio and ranks #52 among its holdings.

48 funds tracked by Wall St. Rank hold HTGM as of Q4 2018.

  • Requisite Energy Fund I held 556 shares of HTG Molecular Diagnostics, Inc. Common Stock worth $254K as of Q4 2018.
  • HTG Molecular Diagnostics, Inc. Common Stock was a new Requisite Energy Fund I position in Q4 2018.
  • HTG Molecular Diagnostics, Inc. Common Stock made up 0.1% of Requisite Energy Fund I's portfolio in Q4 2018, its #52 holding.
  • 48 funds tracked by Wall St. Rank held HTG Molecular Diagnostics, Inc. Common Stock as of Q4 2018.

Based on Requisite Energy Fund I's 13F filing for Q4 2018, filed 14 Feb 2019.